Alyce C. Katayama
Quarles & Brady LLP
Articles
“The Omnibus Guidance is Dead!”
USA - February 2 2017 The proposed 340B Drug Pricing Program Omnibus Guidance that was issued in August 2015 and promised to turn the 340B world on its head was withdrawn...
Board Diversity Strategies
USA - August 25 2016 Board diversity and director tenure continue to be “hot” governance topics. For example, last week CalPERS publicly released its new environmental...
So Long, Farewell, Auf Wiedersehen, Goodbye: CMS Proposed Regulations Say Good Night to HAIs and MDROs
USA - July 14 2016 The Centers for Medicare & Medicaid Services (CMS) has issued a proposed update to the conditions of participation (CoPs) that hospitals and critical...
The 340b program mega guidance: muddying the water for all stakeholders
USA - October 1 2015 Ask and ye shall finally receivethe long-awaited proposed 340B Drug Pricing Program Omnibus Guidance (Guidance) was published in the Federal Register...
Edward D. Rickert, Elizabeth R. Gebarski, Brenda M. Maloney Shafer.
Health care reform: what’s resolved and what is not
USA - July 28 2015 Late last month, the Supreme Court ruled in King v. Burwell that the health insurance subsidies for low- and middle-income taxpayers, made possible...
